triple hormone receptor agonist retatrutide for obesity Triple–Hormone-Receptor — A Phase 2 Trial | NEJM triple-hormone-receptor agonist retatrutide for obesity
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16



























